ng-nitroarginine methyl ester has been researched along with Hypertension, Malignant in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grujić-Milanović, J; Ivanov, M; Jaćević, V; Jovović, D; Karanović, D; Mihailović-Stanojević, N; Milanović, SD; Miloradović, Z; Vajić, UJ | 1 |
| Grujić-Milanović, J; Jaćević, V; Jovović, D; Mihailović-Stanojević, N; Milanović, SD; Miloradović, Z; Milosavljević, I | 1 |
| Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F | 1 |
| Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Takahashi, T | 1 |
4 other study(ies) available for ng-nitroarginine methyl ester and Hypertension, Malignant
| Article | Year |
|---|---|
Resveratrol improved kidney function and structure in malignantly hypertensive rats by restoration of antioxidant capacity and nitric oxide bioavailability.
Topics: Animals; Antioxidants; Biological Availability; Blood Pressure; Hypertension; Hypertension, Malignant; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Resveratrol | 2022 |
Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cardiotonic Agents; Female; Heart Ventricles; Hemodynamics; Hypertension, Malignant; Inflammation; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Oxidation-Reduction; Rats, Inbred SHR; Resveratrol; Thiobarbituric Acid Reactive Substances | 2021 |
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency | 2009 |
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Malignant; Male; Mineralocorticoid Receptor Antagonists; Nephrosclerosis; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Inbred SHR; RNA, Messenger; Spironolactone; Telmisartan; Transforming Growth Factor beta1 | 2007 |